Literature DB >> 31183587

WHO grade I meningiomas: classification-tree for prognostic factors of survival.

Jean-Michel Lemée1,2, Holger Joswig3, Michele Da Broi4, Marco Vincenzo Corniola3, David Scheie5, Karl Schaller3,6, Eirik Helseth4,7, Torstein R Meling3,4,6,7.   

Abstract

World Health Organization (WHO) grade I meningiomas are intracranial extracerebral tumors, in which microsurgery as a stand-alone therapy provides high rates of disease control and low recurrence rates. Our aim was to identify prognostic factors of overall survival and time-to-retreat (OS; TTR) in a cohort of patients with surgically managed WHO grade I meningioma. Patients with WHO grade I meningiomas from a retrospectively (1990 to 2002) and prospectively managed (2003 to 2010) databank of Oslo University Hospital, Norway, were included. The mean follow-up was 9.2 ± 5.7 years, with a total of 11,414 patient-years. One thousand three hundred fifty-five patients were included. The mean age was 58 ± 13.2, mean Karnofsky Performance Status (KPS) 92.6 ± 26.1 and female-to-male ratio 2.5:1. The 1-year, 5-year, 10-year, 15-year, and 20-year probabilities were 0.98, 0.91, 0.87, 0.84, and 0.8 for TTR. Patient age (OR 0.92 [0.91, 0.94]), male sex (OR 0.59 [0.45, 0.76]), preoperative KPS ≥ 70 (OR 2.22 [1.59, 3.13]), skull base location (OR 0.77 [0.60, 1]), and the occurrence of a postoperative hematoma (OR 0.44 [0.26, 0.76]) were identified as independent prognostic factors of OS. Patient age (OR 1.02 [1.01, 1.03]) and skull base location (OR 0.30 [0.21, 0.45]) were independent predictors of decreased PFS. Using a recursive partitioning analysis, we suggest a classification tree for the prediction of 5-year PFS based on patient and tumor characteristics. The findings from this cohort of meningioma WHO I patients helps to identify patients at risk of recurrence and tailor the therapeutic management.

Entities:  

Keywords:  Meningioma; Overall survival; Prognostic factors; Time-to-retreat; WHO grade I

Mesh:

Year:  2019        PMID: 31183587     DOI: 10.1007/s10143-019-01117-0

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  55 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Outcome following surgery for intracranial meningiomas in the aging.

Authors:  A Konglund; S G Rogne; M Lund-Johansen; D Scheie; E Helseth; T R Meling
Journal:  Acta Neurol Scand       Date:  2012-06-22       Impact factor: 3.209

Review 3.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

4.  Descriptive epidemiology of 13,038 newly diagnosed and histologically confirmed meningiomas in France: 2006-2010.

Authors:  S Zouaoui; A Darlix; V Rigau; H Mathieu-Daudé; F Bauchet; F Bessaoud; P Fabbro-Peray; B Trétarre; D Figarella-Branger; L Taillandier; H Loiseau; L Bauchet
Journal:  Neurochirurgie       Date:  2018-03       Impact factor: 1.553

5.  Skull base versus non-skull base meningioma surgery in the elderly.

Authors:  Torstein R Meling; Michele Da Broi; David Scheie; Eirik Helseth
Journal:  Neurosurg Rev       Date:  2018-07-05       Impact factor: 3.042

6.  Genomic landscape of intracranial meningiomas.

Authors:  Wenya Linda Bi; Malak Abedalthagafi; Peleg Horowitz; Pankaj K Agarwalla; Yu Mei; Ayal A Aizer; Ryan Brewster; Gavin P Dunn; Ossama Al-Mefty; Brian M Alexander; Sandro Santagata; Rameen Beroukhim; Ian F Dunn
Journal:  J Neurosurg       Date:  2016-01-15       Impact factor: 5.115

7.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  A B Adegbite; M I Khan; K W Paine; L K Tan
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

8.  Meningioma Surgery-Are We Making Progress?

Authors:  Torstein R Meling; Michele Da Broi; David Scheie; Eirik Helseth; Nicolas R Smoll
Journal:  World Neurosurg       Date:  2019-01-24       Impact factor: 2.104

Review 9.  Surgical management of jugular foramen meningiomas: a series of 13 cases and review of the literature.

Authors:  Mario Sanna; Andrea Bacciu; Maurizio Falcioni; Abdelkader Taibah; Paolo Piazza
Journal:  Laryngoscope       Date:  2007-10       Impact factor: 3.325

10.  Risk of Recurrence in Operated Parasagittal Meningiomas: A Logistic Binary Regression Model.

Authors:  José Alberto Escribano Mesa; Enrique Alonso Morillejo; Tesifón Parrón Carreño; Antonio Huete Allut; José María Narro Donate; Paddy Méndez Román; Ascensión Contreras Jiménez; Francisco Pedrero García; José Masegosa González
Journal:  World Neurosurg       Date:  2017-10-26       Impact factor: 2.104

View more
  3 in total

1.  Why we need new classification models in meningioma management.

Authors:  Marco V Corniola
Journal:  Acta Neurochir (Wien)       Date:  2022-01-24       Impact factor: 2.216

2.  Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification.

Authors:  Juan Yu; Fan-Fan Chen; Han-Wen Zhang; Hong Zhang; Si-Ping Luo; Guo-Dong Huang; Fan Lin; Yi Lei; Liangping Luo
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 3.  Management of Recurrent Meningiomas: State of the Art and Perspectives.

Authors:  Marco Vincenzo Corniola; Torstein R Meling
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.